21 May 2026
Shaily Engineering Plastics receives regulatory approval and launches a combination drug product incorporating its ShailyPen Neo device technology.
The wearable drug delivery segment is a high-barrier, high-value niche with growing global pharma outsourcing potential for contract device manufacturers.